DV
Dividend Vision

BETRF — BetterLife Pharma Inc

BetterLife Pharma Inc (BETRF)

Total return is -97.1% over the past 15.6 years, 784.8 points behind SPY at 687.7%. Its deepest 1-year drawdown was 56.1%.

BETRF is a healthcare-focused equity stock with roots dating to 2011. The fund operates within the pharmaceutical sector, though specific details regarding its underlying holdings strategy, distribution frequency, and expense ratio are not currently available. The absence of a stated distribution rate suggests this security may prioritize capital appreciation over income generation, potentially appealing more to growth-oriented investors than those seeking regular dividend income.

BETRF key facts

Asset type
Stock
Asset class
Equity
Inception date
01/18/2011
Last close
$0.20
Market cap
$33,472,064
Average volume
87100.0
Payment date
06/26/2020
Beta
0.223
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.01